Echovirus IgG Control Serum BC135G

$94.00

Summary

Virion/Serion Diagnostic Kit Control for research use (RUO)
Echovirus IgG Control Serum
Applications: ELISA
IgG control serum
Ready-to-use; pre-diluted for SERION ELISA classic and SERION ELISA antigen assays
3 mL

SKU: BC135G Categories: control serum, Virion/Serion kits Tags: Echovirus, ELISA control serum, IgG

Weight	1 lbs
Dimensions	9 × 5 × 2 in
target	Echovirus reactive IgG
species reactivity	Echovirus
applications	ELISA
assay type	Indirect & quantitative
available size	3 mL

Echovirus IgG Control Serum BC135G

kit
Research area Infectious Disease
Storage Store at 2-8°C.
Associated products Echovirus Antigen (BA135VS01) Echovirus IgA Control Serum (BC135A) Echovirus IgG Control Serum (BC135G) Echovirus IgM Control Serum (BC135M) Echovirus IgG ELISA Kit (ESR135G) Echovirus IgA ELISA Kit (ESR135A) Echovirus IgM ELISA Kit (ESR135M)

target relevance

human antibody anti-Echovirus

Echovirus

Description
Group of enteroviruses that cause aseptic meningitis, febrile illness, and other systemic infections

Structure
Echoviruses (Enteric Cytopathic Human Orphan viruses) are non-enveloped, positive-sense, single-stranded RNA viruses belonging to the genus Enterovirus within the family Picornaviridae. The viruses possess an icosahedral capsid that protects the viral genome and contributes to their resistance to environmental conditions and many disinfectants. Echoviruses are transmitted primarily through the fecal-oral route, respiratory secretions, and direct contact with contaminated surfaces. Following infection, viral replication occurs in the gastrointestinal tract and upper respiratory tract before dissemination through the bloodstream to various tissues and organs. More than thirty echovirus serotypes have been identified, and they are distributed worldwide. Echoviruses are among the most common causes of enteroviral infections and are frequently associated with outbreaks in children, although infections occur in all age groups.

Diagnosis
The diagnosis of echovirus infection is performed through molecular, virological, and serological methods. Reverse transcription polymerase chain reaction (RT-PCR) is the preferred diagnostic method due to its high sensitivity and specificity and can detect viral RNA in cerebrospinal fluid, stool samples, throat swabs, blood, and other clinical specimens. Viral culture may be performed in specialized laboratories but has largely been supplanted by molecular testing. Serological assays can detect echovirus-specific antibodies and may be useful for epidemiological investigations or retrospective diagnosis. Laboratory confirmation is particularly important in patients presenting with meningitis, encephalitis, neonatal infections, myocarditis, or unexplained febrile illness.

Symptoms
Echovirus infections produce a broad spectrum of clinical manifestations ranging from asymptomatic infection to severe systemic disease. Common symptoms include fever, headache, sore throat, fatigue, muscle aches, nausea, vomiting, abdominal pain, and rash. Echoviruses are a major cause of aseptic meningitis, which typically presents with fever, severe headache, neck stiffness, photophobia, and cerebrospinal fluid pleocytosis. Less commonly, echoviruses may cause encephalitis, myocarditis, pericarditis, hepatitis, conjunctivitis, and neonatal sepsis-like illness. Newborns and immunocompromised individuals are at increased risk of severe disease, which may result in multi-organ involvement and significant morbidity. Most infections are self-limiting and resolve without long-term complications.

Data

FAQ & Publications

Frequently Asked Questions

What is the intended application for the Echovirus IgG Control Serum BC135G?

The Echovirus IgG Control Serum BC135G is designed for use as a control serum in ELISA applications, specifically compatible with SERION ELISA classic and SERION ELISA antigen assays to detect Echovirus reactive IgG antibodies.

How should the Echovirus IgG Control Serum BC135G be stored to maintain its stability?

The Echovirus IgG Control Serum BC135G should be stored at 2-8°C to preserve its stability and efficacy for research use.

Publications

pmid	title	authors	citation
We haven't added any publications to our database yet.

Published literature highly relevant to the biological target of this product and referencing this antibody or clone are retrieved from the PubMed database provided by the United States National Library of Medicine at the National Institutes of Health.

Protocols

relevant to this product
BC135G protocol

Documents

#
Please enter your product and batch number here.

Reviews

There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.

Echovirus IgG Control Serum BC135G

Data

FAQ & Publications

Protocols

Documents

Related Technical Resources & Posts

Reviews

Related Products

Cytomegalovirus IgG Control Serum BC109G

Brucella IgG Control Serum BC116G

Echovirus IgA Control Serum BC135A

Borrelia burgdorferi IgG Control Serum BC121G

Echovirus IgM Control Serum BC135M

Bordetella pertussis IgG Control Serum BC120G

Echinococcus IgG Control Serum BC107G

Aspergillus fumigatus IgG Control Serum BC132G

Diphtheria IgG Control Serum BC130G

Adenovirus IgG Control Serum BC128G

Coxsackie IgG Virus Control Serum BC134G

Chlamydia trachomatis IgG Control Serum BC1372G

Chlamydia pneumoniae IgG Control Serum BC1371G

Candida albicans IgG Control Serum BC117G

Campylobacter jejuni IgG Control Serum BC139G